326 related articles for article (PubMed ID: 24283604)
1. Current and future evidence-based acne treatment: a review.
Sandoval LF; Hartel JK; Feldman SR
Expert Opin Pharmacother; 2014 Feb; 15(2):173-92. PubMed ID: 24283604
[TBL] [Abstract][Full Text] [Related]
2. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D
J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176
[TBL] [Abstract][Full Text] [Related]
3. Tolerability of topical antimicrobials in treatment of acne vulgaris.
Bartlett KB; Davis SA; Feldman SR
J Drugs Dermatol; 2014 Jun; 13(6):658-62. PubMed ID: 24918554
[TBL] [Abstract][Full Text] [Related]
4. Evidence-based recommendations for the diagnosis and treatment of pediatric acne.
Eichenfield LF; Krakowski AC; Piggott C; Del Rosso J; Baldwin H; Friedlander SF; Levy M; Lucky A; Mancini AJ; Orlow SJ; Yan AC; Vaux KK; Webster G; Zaenglein AL; Thiboutot DM;
Pediatrics; 2013 May; 131 Suppl 3():S163-86. PubMed ID: 23637225
[TBL] [Abstract][Full Text] [Related]
5. Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris.
Sagransky M; Yentzer BA; Feldman SR
Expert Opin Pharmacother; 2009 Oct; 10(15):2555-62. PubMed ID: 19761357
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based review: fixed-combination therapy and topical retinoids in the treatment of acne.
Webster GF
J Drugs Dermatol; 2011 Jun; 10(6):636-44. PubMed ID: 21637904
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
Marazzi P; Boorman GC; Donald AE; Davies HD
J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
[TBL] [Abstract][Full Text] [Related]
8. Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability.
Fakhouri T; Yentzer BA; Feldman SR
J Drugs Dermatol; 2009 Jul; 8(7):657-61. PubMed ID: 19588642
[TBL] [Abstract][Full Text] [Related]
9. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne.
Gollnick HP; Graupe K; Zaumseil RP
Eur J Dermatol; 2001; 11(6):538-44. PubMed ID: 11701404
[TBL] [Abstract][Full Text] [Related]
10. Use of systemic agents in the treatment of acne vulgaris.
Johnson BA; Nunley JR
Am Fam Physician; 2000 Oct; 62(8):1823-30, 1835-6. PubMed ID: 11057839
[TBL] [Abstract][Full Text] [Related]
11. Combination of low-dose isotretinoin and pulsed oral azithromycin for maximizing efficacy of acne treatment.
Hasibur MR; Meraj Z
Mymensingh Med J; 2013 Jan; 22(1):42-8. PubMed ID: 23416807
[TBL] [Abstract][Full Text] [Related]
12. Optimizing topical combination therapy for the treatment of acne vulgaris.
Zeichner JA
J Drugs Dermatol; 2012 Mar; 11(3):313-7. PubMed ID: 22395581
[TBL] [Abstract][Full Text] [Related]
13. Changing the face of acne therapy.
Ghali F; Kang S; Leyden J; Shalita AR; Thiboutot DM
Cutis; 2009 Feb; 83(2 Suppl):4-15. PubMed ID: 19363873
[TBL] [Abstract][Full Text] [Related]
14. Practical considerations in acne treatment and the clinical impact of topical combination therapy.
Krakowski AC; Stendardo S; Eichenfield LF
Pediatr Dermatol; 2008 Jun; 25 Suppl 1():1-14. PubMed ID: 18494684
[TBL] [Abstract][Full Text] [Related]
15. Rapid and efficacious fixed-combination monotherapy: desired results for the patient and improved adherence for the clinician.
Kircik L
Cutis; 2009 Nov; 84(5 Suppl):5-11. PubMed ID: 19999187
[TBL] [Abstract][Full Text] [Related]
16. A comparative review of the efficacy and tolerability of retinoid-containing combination regimens for the treatment of acne vulgaris.
Campbell JL
J Drugs Dermatol; 2007 Jun; 6(6):625-9. PubMed ID: 17668528
[TBL] [Abstract][Full Text] [Related]
17. Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris.
Pazoki-Toroudi H; Nilforoushzadeh MA; Ajami M; Jaffary F; Aboutaleb N; Nassiri-Kashani M; Firooz A
Cutan Ocul Toxicol; 2011 Dec; 30(4):286-91. PubMed ID: 21612319
[TBL] [Abstract][Full Text] [Related]
18. Newer approaches in topical combination therapy for acne.
Fu LW; Vender RB
Skin Therapy Lett; 2011 Oct; 16(9):3-6. PubMed ID: 22089505
[TBL] [Abstract][Full Text] [Related]
19. An expert view on the treatment of acne with systemic antibiotics and/or oral isotretinoin in the light of the new European recommendations.
Dréno B; Bettoli V; Ochsendorf F; Perez-Lopez M; Mobacken H; Degreef H; Layton A
Eur J Dermatol; 2006; 16(5):565-71. PubMed ID: 17101480
[TBL] [Abstract][Full Text] [Related]
20. Lack of irritative potential of nadifloxacin 1% when combined with other topical anti-acne agents.
Wilhelm KP; Wilhelm D; Neumeister C; Zsolt I; Schwantes U
Clin Exp Dermatol; 2012 Mar; 37(2):112-7. PubMed ID: 22103435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
